Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 28, 2022 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals to Participate in the 42nd Annual Cowen Health Care Conference

CRANBURY, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
February 03, 2022 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals to Participate in the Guggenheim Healthcare Talks 2022 Oncology Day

CRANBURY, N.J., Feb. 03, 2022 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
January 06, 2022 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharma Announces Changes to its Board of Directors

CRANBURY, N.J., Jan. 06, 2022 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
November 22, 2021 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharma to Present at the Evercore ISI 4th Annual HealthCONx Conference

CRANBURY, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
November 12, 2021 07:15 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Highlights

CRANBURY, N.J., Nov. 12, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a clinical-stage oncology company pioneering the discovery and development of small molecule therapies...
September 09, 2021 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals Appoints Tim Smith as Senior Vice President, Head of Corporate Development

CRANBURY, N.J., Sept. 09, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
September 02, 2021 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

CRANBURY, N.J., Sept. 02, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
August 13, 2021 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights

Continued enrollment in Phase 1/2 trial of first-in-class p53 Y220C reactivator PC14586 CRANBURY, N.J., Aug. 13, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a...
June 09, 2021 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals Announces Participation at the Bank of America Securities 2021 Napa Biopharma Virtual Conference

CRANBURY, N.J., June 09, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
June 03, 2021 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals Announces Participation at the Goldman Sachs Annual Healthcare Conference

CRANBURY, N.J., June 03, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...